logo
Six more states join national milk testing strategy amid rampant spread of bird flu

Six more states join national milk testing strategy amid rampant spread of bird flu

Yahoo18-02-2025
Six states have joined the nation's milk testing program to track the spread of bird flu as another spillover of the virus was reported in dairy cows.
The addition of Arkansas, Louisiana, Nebraska, New Hampshire, North Carolina, and West Virginia, brings the total number of states in the program to 36.
Notably, Texas and Mississippi — some of the nation's largest poultry producers — remain absent. As do Wisconsin and Idaho: some of America's top milk producers.
To date, more than 970 herds have been stricken with bird flu across 17 states, according to data from the Department of Agriculture.
The news comes after Arizona health officials announced on Friday that the state's agriculture department had identified H5N1 bird flu in milk produced by a dairy herd in Maricopa County, although the cattle haven't shown any symptoms. The virus is the D1.1 genotype: the same that had been confirmed in Nevada dairy cattle at the end of last month.
The genotype has also been implicated in human infections, including the death of a Louisiana resident over the age of 65. Shortly after, the state reported its first bird flu infection in a dairy worker exposed to sickened cows.
Wyoming also reported its first infection on Friday in an older woman in Platte County: the third confirmed hospitalization related to bird flu in the U.S. The woman is hospitalized in another state, has conditions that can make people more vulnerable to illness, and was likely exposed through direct contact with an infected flock at her home. While many of those infected experience mild symptoms, state health officials said her experience 'has been much more serious.'
'While this is a significant development as bird flu activity is monitored in Wyoming and across the country, it is not something we believe requires a high level of concern among most Wyoming residents,' said Dr. Alexia Harrist, state health officer and state epidemiologist with the Wyoming Department of Health.
Around the U.S., 68 cases have been confirmed in the West, South, and Great Lakes regions. The majority have been dairy and poultry workers experiencing mild symptoms. Officials maintain that the current risk to the public is low and there has been no known person-to-person transmission of the virus.
Still, the nation's response is under major scrutiny, with scientists voicing concerns about possible pandemic tipping points.
While the Trump administration has addressed the resulting egg shortage, they had not specifically detailed a plan of action to respond to outbreaks tearing across the country. They've placed the blame on the previous administration.
'President Biden didn't really have a plan for avian flu,' White House economic advisor Kevin Hassett told CBS News' Face the Nation on Sunday. 'Well, Brooke Rollins and I have been working with all the best people in government, including academics around the country and around the world, to have a plan ready for the president next week on what we're going to do with avian flu,' said Hassett.
Concerning reports came over the weekend regarding layoffs at Department of Agriculture facilities responding to the outbreak. The department did not immediately reply to The Independent's request for comment.
'They're the front line of surveillance for the entire outbreak,' Keith Poulsen, director of the Wisconsin Veterinary Diagnostic Laboratory, told Politico. 'They're already underwater and they are constantly short-staffed, so if you take all the probationary staff out, you'll take out the capacity to do the work.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trade-offs abound as big pharma makes direct-to-consumer transition
Trade-offs abound as big pharma makes direct-to-consumer transition

Yahoo

time2 hours ago

  • Yahoo

Trade-offs abound as big pharma makes direct-to-consumer transition

Novo Nordisk is the latest drugmaker to slash the price of a blockbuster medicine via its online platform amid drug pricing reforms in the US, but analysis shows a smooth transition to direct-to-consumer (DTC) channels will be tricky. US President Donald Trump has made reducing drug prices in the country one of his administration's key targets. He has spearheaded this goal with the Most Favoured Nation (MFN) policy, a legislative framework that would tie US drug prices to the lowest prices in other developed countries. As part of this push, Trump has urged pharmaceutical companies to embrace DTC business models. This includes companies establishing their own platforms or opting in to those from third parties that cut out middlemen, meaning final drug prices are lower. GlobalData's senior pharma strategic intelligence analyst Wafaa Hassan comments: 'The [DTC] development, closely tied to the administration's 'America First' healthcare agenda and its revived MFN pricing framework, marks a renewed phase of pressure on drugmakers to lower domestic prices while signalling alignment between the White House and the pharmaceutical industry.' Earlier this year, Novo Nordisk unveiled its DTC platform NovoCare Pharmacy with a heavily discounted price for weight loss drug Wegovy (semaglutide). Just this week, the drugmaker added type 2 diabetes treatment Ozempic (semaglutide) to the platform. Both drugs are available to cash-paying patients for $499 each for a monthly supply. The list price of both drugs in the US sits at around $1,300 per month. While the move to discount the two drugs is more likely a response to the popularity of cheaper compounded alternatives, Trump will nevertheless be pleased with Novo's decision. Ozempic – a drug that generated global sales of $10bn in Q2 this year alone – being available for cheaper on a DTC platform is a coup Trump will likely point to in the face of criticism for his pricing reforms. However, challenges such as a limited patient awareness and disruption to traditional distribution channels could hinder the adoption of the DTC models by pharma companies, according to analysis by GlobalData. Hassan adds: 'From a drugmaker perspective, more challenges will occur following the initiatives, such as new operational demands, margin pressure and potential friction with insurers. The likelihood of success will only depend on how well the pharma industry navigates these trade-offs in the upcoming months.' Novo is far from the only big pharma company bolstering DTC medicine offerings. Novo's main rival in the GLP-1RA arena, Eli Lilly, has also conducted similar moves. The company began offering its weight loss medication Zepbound (tirzepatide) to self-paying patients at a steep discount on its own DTC platform LillyDirect in 2024. Taking a page from the two GLP-1RA developers, Bristol Myers Squibb (BMS) and Pfizer also established a DTC online programme for their blockbuster blood thinner Eliquis (apixaban) in July. BMS, Pfizer, Eli Lilly, and Novo Nordisk were among 17 pharma companies to receive a letter from Trump requesting more steps be taken by them to cut drug prices. "Trade-offs abound as big pharma makes direct-to-consumer transition" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Study shows rising popularity of over-the-counter birth control pill
Study shows rising popularity of over-the-counter birth control pill

UPI

time2 hours ago

  • UPI

Study shows rising popularity of over-the-counter birth control pill

Two years after U.S. approval of the first over-the-counter birth control pill, new research shows many people who face barriers to care are turning to it. File Photo by Billie Jean Shaw/UPI Two years after U.S. approval of the first over-the-counter birth control pill, new research shows many people who face barriers to medical care are turning to it. The study, published Monday in JAMA Network Open, included data from 986 people ages 15 to 45 across 44 states. All had obtained the pill -- known as Opill -- either online or from a pharmacy. Researchers found many switched from less effective birth control methods or from using no contraception at all. There was a 31.8% increase in use among people who had previously used no birth control, and a 41% increase among those who had relied on methods like condoms or emergency contraception. Opill, made by drug company Perrigo, is a progestin-only pill that can be bought without a prescription. When the U.S. Food and Drug Administration approved it in 2023, it said the move could help lower barriers to access. At that time, the FDA noted that nearly half of the 6.1 million pregnancies in the U.S. each year are unintended, CBS News reported. "This is one of the first studies to show that over-the-counter birth control pills are reaching the very people they're meant to help -- those who face the greatest barriers to care," said lead study author Dr. Maria Rodriguez, a professor of obstetrics and gynecology at Oregon Health & Science University in Portland. The study found that people using the OTC pill were more often uninsured, younger (15 to 20 years of age), and living in rural areas. The top reason people gave for choosing the OTC pill was that it did not require a doctor's appointment. Others said they did not have a regular physician. "At a time when pregnancy is becoming even more dangerous in the United States -- especially for people of color, those with low incomes and those living in rural communities -- our findings underscore that OTC contraception is a powerful tool for reproductive autonomy," Rodriguez said in a news release. An outside expert who reviewed the findings agreed. Dr. Jessica Shepherd is a board-certified OB/GYN and chief medical officer of the online health company Hers. "While greater access to contraception without prescriptions can be life-changing for women with limited resources, it also highlights how deeply the repercussions of unplanned pregnancies still ripple through health care systems and communities," she told CBS News. "Unplanned pregnancies often result in higher maternal and infant health risks, financial strain and long-term socioeconomic challenges-consequences that weigh most heavily on women who already face barriers to care," Shepherd added. More information Learn more about how Opill works. Copyright © 2025 HealthDay. All rights reserved.

Medicaid Implementing Major Change
Medicaid Implementing Major Change

Newsweek

time2 hours ago

  • Newsweek

Medicaid Implementing Major Change

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The Trump administration's Centers for Medicare & Medicaid Services (CMS) has rolled out a new initiative requiring states to conduct monthly checks on Medicaid and CHIP (Children's Health Insurance Program) enrollees, according to a new report by Fox News' Alec Schemmel. The change would affect those whose citizenship or immigration status cannot be confirmed through federal databases like the Social Security Administration and DHS's SAVE program. According to CMS, the first round of individual reports went out Tuesday to all 50 states and D.C., with states expected to verify status and report back. "We are tightening oversight of enrollment to safeguard taxpayer dollars and guarantee that these vital programs serve only those who are truly eligible under the law," HHS Secretary Robert F. Kennedy Jr. told Fox News. CMS Administrator Dr. Mehmet Oz added that "every dollar misspent is a dollar taken away from an eligible, vulnerable individual in need." This is a breaking news story. Updates to follow.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store